Home › Funds › JACOBS LEVY EQUITY MANAGEMENT, INC › ALGN

JACOBS LEVY EQUITY MANAGEMENT, INC position in ALGN

ALIGN TECHNOLOGY INC · Health Care

JACOBS LEVY EQUITY MANAGEMENT, INC reported holding 1,068,964 shares of ALGN (ALIGN TECHNOLOGY INC) in its Q2 2026 13F filing — a position valued at US$180.3M, representing 0.65% of its reported portfolio and ranking #30 among its reported holdings. JACOBS LEVY EQUITY MANAGEMENT, INC has disclosed ALGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.07M sh
Reported value held$180.29M
Portfolio Weight0.65%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How JACOBS LEVY EQUITY MANAGEMENT, INC's ALGN position evolved

JACOBS LEVY EQUITY MANAGEMENT, INC first disclosed a stake in ALGN in Q3 2023 at 2,106 shares (US$643K). The position peaked in Q2 2026 at 1,068,964 shares, worth US$180.3M. Across 12 filings, JACOBS LEVY EQUITY MANAGEMENT, INC increased the stake 10 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,068,964 shares valued at US$180.3M — an increase of 37,640 shares quarter over quarter.. Notable position changes include a 2106% increase in Q4 2023 (shares rose 20% over the following quarter), a 371% increase in Q1 2024 (shares fell 26% over the following quarter), a 88% increase in Q2 2024 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.11K $643.00K New
Q4 2023 46.45K $12.73M Add
Q1 2024 218.78K $71.74M Add
Q2 2024 411.41K $99.33M Add
Q3 2024 541.13K $137.62M Add
Q4 2024 731.85K $152.60M Add
Q1 2025 736.63K $117.02M Add
Q2 2025 512.95K $97.12M Reduce
Q3 2025 768.26K $96.20M Add
Q4 2025 1.01M $157.06M Add
Q1 2026 1.03M $176.80M Add
Q2 2026 1.07M $180.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALGN and 13F data

ALGN (ALIGN TECHNOLOGY INC) is a Health Care company. 21 other funds we track also report a position in ALGN — the largest reported positions include Ninety One UK Ltd (US$310.1M), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$292.4M), Ruane Cunniff & Goldfarb (Sequoia) (US$197.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALGN

All ALGN fund holders →

FAQ

How long has JACOBS LEVY EQUITY MANAGEMENT, INC held ALGN?

JACOBS LEVY EQUITY MANAGEMENT, INC has disclosed ALGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is JACOBS LEVY EQUITY MANAGEMENT, INC's current position in ALGN?

As of Q2 2026, JACOBS LEVY EQUITY MANAGEMENT, INC holds 1.07M shares of ALGN (ALIGN TECHNOLOGY INC), valued at $180.29M, representing 0.65% of its reported portfolio and ranking #30.

Has JACOBS LEVY EQUITY MANAGEMENT, INC been buying or selling ALGN?

In the latest 13F filing (Q2 2026), JACOBS LEVY EQUITY MANAGEMENT, INC increased its position in ALGN. The position peaked in Q2 2026 at 1.07M shares.

Which other funds hold ALGN?

Other major institutional holders of ALGN include Ninety One UK Ltd, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Ruane Cunniff & Goldfarb (Sequoia), among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.